Astrazeneca Pharma India Q3 Results
- BSE: 506820
- NSE: ASTRAZEN
- ISIN: INE203A01020
- Sector: Major Drugs
BSE
6,455.4
118.50 (1.87%)
118.50 (1.87%)Volume1.48 K
Updated: Mon 25 Nov, 2024 | 15:58:52
NSE
6,457.15137.30 (2.17%)
137.30 (2.17%)Volume14.74 K
Updated: Mon 25 Nov, 2024 | 15:44:21
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Astrazeneca Pharma India Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 305.79 | 311.07 | -% | 249.81 | -% |
| Selling/ General/ Admin Expenses Total | 91.56 | 82.02 | -% | 83.93 | -% |
| Depreciation/ Amortization | 3.70 | 3.67 | -% | 4.13 | -% |
| Other Operating Expenses Total | 50.89 | 54.16 | -% | 37.82 | -% |
| Total Operating Expense | 294.44 | 245.56 | -% | 217.35 | -% |
| Operating Income | 11.35 | 65.51 | -% | 32.46 | -% |
| Net Income Before Taxes | 20.40 | 73.38 | -% | 39.46 | -% |
| Net Income | 15.80 | 52.37 | -% | 29.30 | -% |
| Diluted Normalized EPS | 6.32 | 16.26 | -% | 11.72 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST